Arnold is looking to catch drug deals in progress now that Oregon's three-and-a-half-year experiment with decriminalization ...
Builders have expressed concern over a slew of labor, environmental, and safety mandates they argue have suppressed competitiveness.
Treatment of Parkinson's and Lewy body patient brain tissue with WTX-607 demonstrated highly specific binding to aggregates within neurons in patients' ...
See why The Progressive Corporation's profit margins face pressure amid rising AI-driven competition and repair costs. Learn ...
Far more partisan than the straightforward alerts that typically grace agency websites during shutdowns, the messages are in ...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...
BlueRock Therapeutics reports positive 36-month results from phase I trial of bemdaneprocel for treating Parkinson’s disease: Berlin, Germany Wednesday, October 8, 2025, 18:00 H ...
Introduction Only symptomatic treatments are available for patients with Parkinson’s disease (PD), the second most common chronic neurodegenerative disease worldwide, and it is therefore imperative to ...
Despite being under threat from the Trump Administration, progressive lawyers continue to advocate for immigrants, LGBTQ+ ...
For a long time, progressives argued the Democratic Party should focus on turning out its disaffected voters and pay little ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback